Ethicon introduces absorbable suture in UK:
This article was originally published in Clinica
Executive Summary
Ethicon has launched Monocryl, its pliable monofilament absorbable suture, in the UK. The suture has double the initial strength of chromic catgut and equivalent knot security to other absorbables. Unlike catgut, Monocryl has a predictable loss of tensile strength because it is achieved by systematic hydrolysis. The product provides predictable strength retention through the critical 14 days after implantation and is appropriate for gastrointestinal, plastic, gynaecological and obstetric surgeries. Monocryl has been available in the US since 1993.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.